Mast Cells: A New Frontier for Cancer Immunotherapy

Mast Cells: A New Frontier for Cancer Immunotherapy

Mast cells are unique tissue-resident immune cells of the myeloid lineage that have long been implicated in the pathogenesis of allergic and autoimmune disorders. More recently, mast cells have been recognized as key orchestrators of anti-tumor immunity, modulators of the cancer stroma, and have als...

Full description

Bibliographic Details
Main Authors:	Jake N. Lichterman, Sangeetha M. Reddy
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Cells
Subjects:	mast cell cancer immunotherapy microenvironment cancer immunology c-KIT
Online Access:	https://www.mdpi.com/2073-4409/10/6/1270

Similar Items

Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
by: Roberta Sulsenti, et al.
Published: (2023-06-01)

Comparison of KIT patterns and infiltration of eosinophils in canine mast cell tumor
by: C.D. Araújo, et al.
Published: (2023-11-01)

The Controversial Role of Intestinal Mast Cells in Colon Cancer
by: Rosa Molfetta, et al.
Published: (2023-01-01)

Editorial: Novel insights into inflammatory roles of mast cells and basophils
by: Satoshi Tanaka, et al.
Published: (2023-03-01)

Outcome of adjuvant chemotherapy with lomustine, vinblastine and chlorambucil on management of canine mast cell tumour of high to intermediate risk
by: R.S. Horta, et al.

Mast Cell Activation Disorders
by: Arianna Giannetti, et al.
Published: (2021-01-01)

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H
by: Peter Valent, et al.
Published: (2014-01-01)

The exon-skipping oligonucleotide, KitStop, depletes tissue-resident mast cells in vivo to ameliorate anaphylaxis
by: Barry A. Hedgespeth, et al.
Published: (2023-01-01)

Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
by: Hae Woong Choi, et al.
Published: (2021-10-01)

Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
by: Katerina Kalkusova, et al.
Published: (2022-09-01)

CREB Is Indispensable to KIT Function in Human Skin Mast Cells—A Positive Feedback Loop between CREB and KIT Orchestrates Skin Mast Cell Fate
by: Gürkan Bal, et al.
Published: (2023-12-01)

Mast Cell Desensitization in Allergen Immunotherapy
by: Celia López-Sanz, et al.
Published: (2022-06-01)

Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue
by: Michele Ammendola, et al.
Published: (2021-02-01)

Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway
by: Yipin Lv, et al.
Published: (2019-02-01)

Tumor–Microenvironment Interaction: Analysis of Mast Cell Populations in Normal Tissue and Proliferative Disorders of the Canine Prostate
by: Sabrina Vanessa Patrizia Defourny, et al.
Published: (2019-02-01)

The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer
by: Guilherme Sacchi de Camargo Correia, et al.
Published: (2024-02-01)

Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone
by: Thais Rodrigues Macedo, et al.
Published: (2022-02-01)

RNAScope in situ Hybridization as a Novel Technique for the Assessment of c-KIT mRNA Expression in Canine Mast Cell Tumor
by: Davide De Biase, et al.
Published: (2021-02-01)

Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells
by: Jesse D. Plotkin, et al.
Published: (2019-02-01)

Frontiers in Tumor Immunity : Grand Challenge Cancer and Immunity : a family drama
by: Wolf Hervé eFridman, et al.
Published: (2011-08-01)

Targeting the hypoxic tumour phenotype with T-cell immunotherapy
by: Chong, T
Published: (2004)

Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
by: Mohammad Fereydouni, et al.
Published: (2022-03-01)

Mast cells in oral lichen planus and oral lichenoid lesions related to dental amalgam contact
by: Mariana Saturnino de NORONHA, et al.
Published: (2024-01-01)

Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas
by: Rui Chen, et al.
Published: (2022-09-01)

CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis
by: Geethani Bandara, et al.
Published: (2023-03-01)

Mast Cells and Skin and Breast Cancers: A Complicated and Microenvironment-Dependent Role
by: Mark R. Hanes, et al.
Published: (2021-04-01)

Selective immunocapture reveals neoplastic human mast cells secrete distinct microvesicle‐ and exosome‐like populations of KIT‐containing extracellular vesicles
by: Annika Pfeiffer, et al.
Published: (2022-10-01)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
by: Mazdak Ganjalikhani Hakemi, et al.
Published: (2023-06-01)

MAST CELLS, MAST/STEM CELL GROWTH FACTOR RECEPTOR (C-KIT/CD117) AND IGE MAY BE INTEGRAL TO THE PATHOGENESIS OF ENDEMIC PEMPHIGUS FOLIACEUS
by: Ana Maria Roselino, et al.
Published: (2013-11-01)

Mutations in Exons 8 and 11 of <i>c-kit</i> Gene in Canine Subcutaneous Mast Cell Tumors and Their Association with Cell Proliferation
by: Polly Chen, et al.
Published: (2022-09-01)

Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response
by: Yang Su, et al.
Published: (2023-01-01)

Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention
by: Stephanie A. Legere, et al.
Published: (2019-03-01)

Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis
by: Xiaoxin Liu, et al.
Published: (2023-07-01)

The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs
by: Fabio Gentilini, et al.
Published: (2020-02-01)

Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy
by: Amit Gutwillig, et al.
Published: (2022-09-01)

Mast cell deficiency attenuates acupuncture analgesia for mechanical pain using c-kit gene mutant rats
by: Cui X, et al.
Published: (2018-03-01)

Quantitative mast cell analysis and hormone receptor study (ER, PR and HER2/neu) in invasive carcinoma of breast
by: Rama D Pyla, et al.
Published: (2020-01-01)

Mast Cell Leukemia: An Update with a Practical Review
by: Magda Zanelli, et al.
Published: (2023-03-01)

T Cell Dysfunction in Cancer Immunity and Immunotherapy
by: Anliang Xia, et al.
Published: (2019-07-01)

Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment
by: Shan Wang, et al.
Published: (2016-03-01)